Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06662357 · ClinicalTrials.gov registry record · NA
Family Connections
A NA study of Emotional Disturbance and Behavior Disorders in Children, sponsored by Cambridge Health Alliance.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06662357: Recruiting NA study of Emotional Disturbance and Behavior Disorders in Children, sponsored by Cambridge Health Alliance.
NCT06662357 is a NA study of Emotional Disturbance and Behavior Disorders in Children that is actively recruiting participants, run by Cambridge Health Alliance. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06662357, a NA study of Emotional Disturbance and Behavior Disorders in Children, is actively recruiting participants, sponsored by Cambridge Health Alliance.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The Family Connections study, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Family Connections" will use mobile clinical and family support teams to improve mental health outcomes. This clinical innovation, nested in an integrated system-of-care will be piloted for children, ages 3-18 yrs., with SED who receive primary care through Cambridge Health Alliance.
Primary Outcome
Comparative analysis of baseline and follow-up clinical functioning scores CAFAS Scoring: Levels of Dysfunction None or minimal 0-10 Mild 20-30 Moderate 40-60 Marked 70-80 Severe \>90
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Treatment
Study Locations (1)
Massachusetts
- Cambridge Health Alliance - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-01-30 |
| Est. Completion | 2028-09-29 |
| Phase | NA |
What NCT06662357 shows while recruiting
NCT06662357 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Emotional Disturbance appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Treatment is the first listed.
NCT06662357 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06662357 about?
NCT06662357 is a clinical study titled "Family Connections". The Family Connections study, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Family Connections" will use mobile clinical and family support teams to improve mental health outcomes. Th...
What is the current status of trial NCT06662357?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-01-30. Estimated completion is 2028-09-29.
What conditions does trial NCT06662357 study?
This clinical trial studies the following conditions: Emotional Disturbance, Behavior Disorders in Children.
What interventions are being tested in trial NCT06662357?
The interventions under investigation include: Behavioral Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06662357?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06662357 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emotional Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06662357's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI